1. Market Research
  2. > Pharmaceutical Market Trends
  3. > Ukraine Pharmaceuticals and Healthcare Report Q4 2016

Ukraine Pharmaceuticals and Healthcare Report Q4 2016

  • October 2016
  • -
  • Business Monitor International
  • -
  • 84 pages

Includes 3 FREE quarterly updates

BMI View:

While the challenging business environment in Ukraine will continue to pose risks to multinational pharmaceutical firms operating in the country, the much-needed reforms of the healthcare sector are moving closer to realisation. This will significantly boost prospects for drugmakers, where growth potential is considerable given the market's current underdevelopment.


Headline Expenditure Projections Pharmaceuticals: UAH46.8bn (USD2.13bn) in 2015 to UAH54.0bn (USD2.09bn) in 2016; +15.2% in local currency terms and -2.0% in US dollar terms. Forecast in local currency terms revised upwards compared to the previous quarter. Healthcare: UAH113.9bn (USD5.19bn) in 2015 to UAH117.5bn (USD4.55bn) in 2016; 3.2% in local currency terms and -12.3% in US dollar terms. Forecast revised upwards compared to the previous quarter. In Q416, Ukraine is ranked as the 14th most attractive market in the Central and Eastern Europe region same as in Q316, scoring 49.5 out of 100. Ukraine's score is still under pressure due to the perilous condition of the country's economy, the depreciation of the local currency against the dollar and the bleak short-term outlook.

Table Of Contents

Ukraine Pharmaceuticals and Healthcare Report Q4 2016
BMI Industry View 7
Table: Headline Pharmaceuticals and Healthcare Forecasts (Ukraine 2014-2020) 7
SWOT 9
Industry Forecast 11
Pharmaceutical Market Forecast 11
Table: Pharmaceutical Sales, Historical Data And Forecasts (Ukraine 2012-2020) 13
Healthcare Market Forecast 14
Table: Healthcare Expenditure Trends, Historical Data And Forecasts (Ukraine 2012-2020) 16
Table: Government Healthcare Expenditure Trends, Historical Data And Forecasts (Ukraine 2012-2020) 16
Table: Private Healthcare Expenditure Trends, Historical Data And Forecasts (Ukraine 2012-2020) 17
Ukraine 18
Table: Prescription Drug Market Indicators, Historical Data And Forecasts (Ukraine 2012-2020) 19
Patented Drug Market Forecast 20
Table: Patented Drug Market Indicators, Historical Data And Forecasts (Ukraine 2012-2020) 21
Generic Drug Market Forecast 22
Table: Generic Drug Market Indicators, Historical Data And Forecasts (Ukraine 2012-2020) 23
Ukraine 24
Table: Over-The-Counter (OTC) Medicine Market Indicators, Historical Data And Forecasts (Ukraine 2012-2020) 25
Pharmaceutical Trade Forecast 26
Table: Pharmaceutical Trade Data And Forecasts (Ukraine 2014-2020) 27
Table: Pharmaceutical Trade Data And Forecasts Local Currency (Ukraine 2014-2020) 28
Industry Risk/Reward Index 29
Central And Eastern Europe Risk/Reward Index - Q4 2016 29
Ukraine Risk/Reward Index 36
Rewards 36
Risks 37
Regulatory Review 38
Recent Regulatory Developments 40
Intellectual Property Issues 43
Pricing Regime 44
Reimbursement Regime 47
Market Overview 49
Healthcare System 50
Table: Healthcare Resources (Ukraine 2010-2015) 53
Table: Healthcare Personnel (Ukraine 2010-2015) 53
Table: Healthcare Activity (Ukraine 2010-2015) 54
Research And Development 54
Clinical Trials 55
Ukraine Pharmaceuticals and Healthcare Report Q4 2016$$
Epidemiology 56
Competitive Landscape 60
Research-Based Industry 60
Table: Association of International Manufacturers (AIPM) Ukraine Members, 2015 61
Table: Multinational Market Activity 62
Generic Drugmakers 63
Pharmaceutical Distribution 65
Pharmaceutical Retail Sector 66
Company Profile 68
Arterium 68
Farmak 71
Demographic Forecast 73
Table: Population Headline Indicators (Ukraine 1990-2025) 74
Table: Key Population Ratios (Ukraine 1990-2025) 74
Table: Urban/Rural Population and Life Expectancy (Ukraine 1990-2025) 75
Table: Population By Age Group (Ukraine 1990-2025) 75
Table: Population By Age Group % (Ukraine 1990-2025) 76
Glossary 78
Methodology 80
Pharmaceutical Expenditure Forecast Model 80
Healthcare Expenditure Forecast Model 80
Notes On Methodology 81
Risk/Reward Index Methodology 82
Index Overview 83
Table: Pharmaceutical Risk/Reward Index Indicators 83
Indicator Weightings 84

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024

PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024

  • $ 10995
  • Industry report
  • September 2016
  • by Global Data

PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024 Summary Attention deficit hyperactivity disorder (ADHD) is characterized by excessive levels ...

Global Pharmaceutical Contract Manufacturing Organization (CMO) Market

Global Pharmaceutical Contract Manufacturing Organization (CMO) Market

  • $ 7000
  • Industry report
  • August 2016
  • by Frost & Sullivan

Emerging Business Models Drive Transformation The key objective of this research is to provide in-depth knowledge of the major global pharmaceutical CMO market segments—active pharmaceutical ingredients ...

Frontier Pharma: Asthma Therapeutics - Cytokine and Kinase Targeted Small Molecules and mAbs Increase Pipeline Diversity and Dominate First-in-Class Innovation

Frontier Pharma: Asthma Therapeutics - Cytokine and Kinase Targeted Small Molecules and mAbs Increase Pipeline Diversity and Dominate First-in-Class Innovation

  • $ 6995
  • Industry report
  • November 2016
  • by GBI Research

Frontier Pharma: Asthma Therapeutics - Cytokine and Kinase Targeted Small Molecules and mAbs Increase Pipeline Diversity and Dominate First-in-Class Innovation Summary Asthma is a chronic condition affecting ...


ref:plp2016

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.